Adams Asset Advisors Stake in Myriad Genetics (MYGN) Has Lowered by $1.76 Million as Stock Value Rose; Truepoint Raised Its Procter & Gamble Co (PG) Position

February 12, 2018 - By Hazel Jackson

Truepoint Inc increased its stake in Procter & Gamble Co (PG) by 8711.32% based on its latest 2017Q3 regulatory filing with the SEC. Truepoint Inc bought 26.58M shares as the company’s stock declined 5.32% while stock markets rallied. The institutional investor held 26.89 million shares of the package goods and cosmetics company at the end of 2017Q3, valued at $26.89 million, up from 305,172 at the end of the previous reported quarter. Truepoint Inc who had been investing in Procter & Gamble Co for a number of months, seems to be bullish on the $205.53B market cap company. The stock increased 2.01% or $1.6069 during the last trading session, reaching $81.5269. About 7.01 million shares traded. The Procter & Gamble Company (NYSE:PG) has risen 7.54% since February 12, 2017 and is uptrending. It has underperformed by 9.16% the S&P500.

Adams Asset Advisors Llc decreased its stake in Myriad Genetics Inc (MYGN) by 55.44% based on its latest 2017Q3 regulatory filing with the SEC. Adams Asset Advisors Llc sold 48,906 shares as the company’s stock rose 13.21% with the market. The institutional investor held 39,301 shares of the health care company at the end of 2017Q3, valued at $1.42 million, down from 88,207 at the end of the previous reported quarter. Adams Asset Advisors Llc who had been investing in Myriad Genetics Inc for a number of months, seems to be less bullish one the $2.34 billion market cap company. The stock increased 2.61% or $0.86 during the last trading session, reaching $33.82. About 371,373 shares traded. Myriad Genetics, Inc. (NASDAQ:MYGN) has declined 37.47% since February 12, 2017 and is downtrending. It has underperformed by 54.17% the S&P500.

Adams Asset Advisors Llc, which manages about $828.72 million and $733.52 million US Long portfolio, upped its stake in Calumet Specialty Prod (NASDAQ:CLMT) by 112,648 shares to 817,980 shares, valued at $6.83M in 2017Q3, according to the filing. It also increased its holding in Dorchester Minerals Lp (NASDAQ:DMLP) by 35,286 shares in the quarter, for a total of 519,281 shares, and has risen its stake in Plains All American Pipelinelp (NYSE:PAA).

Since September 1, 2017, it had 0 buys, and 8 selling transactions for $6.39 million activity. Shares for $118,934 were sold by King Gary A. on Thursday, January 18. $909,040 worth of Myriad Genetics, Inc. (NASDAQ:MYGN) shares were sold by HENDERSON JOHN T. $248,925 worth of stock was sold by GILBERT WALTER PHD on Thursday, December 14. Shares for $201,000 were sold by DREISMANN HEINRICH.

Investors sentiment decreased to 0.86 in Q3 2017. Its down 0.16, from 1.02 in 2017Q2. It fall, as 33 investors sold MYGN shares while 72 reduced holdings. 28 funds opened positions while 62 raised stakes. 71.79 million shares or 8.95% less from 78.85 million shares in 2017Q2 were reported. Northern Tru holds 0.01% or 1.53 million shares in its portfolio. Moreover, Commerzbank Aktiengesellschaft Fi has 0.01% invested in Myriad Genetics, Inc. (NASDAQ:MYGN). Tci Wealth Advsrs holds 19 shares. Moreover, Bamco New York has 0.04% invested in Myriad Genetics, Inc. (NASDAQ:MYGN). 5,231 are owned by Kbc Gp Nv. 415,817 are owned by Ameriprise. 43,115 are owned by Pub Sector Pension Board. State Board Of Administration Of Florida Retirement Sys has 0.01% invested in Myriad Genetics, Inc. (NASDAQ:MYGN) for 93,923 shares. Fisher Asset reported 0.01% of its portfolio in Myriad Genetics, Inc. (NASDAQ:MYGN). Systematic Fincl Mgmt Lp reported 46,425 shares. Tiaa Cref has invested 0% in Myriad Genetics, Inc. (NASDAQ:MYGN). Teachers Retirement Systems Of The State Of Kentucky reported 23,600 shares. 29,888 were reported by Price T Rowe Inc Md. Aqr Cap Mgmt Lc has 0.01% invested in Myriad Genetics, Inc. (NASDAQ:MYGN). Ls Invest Advisors Lc invested in 2,541 shares.

Among 20 analysts covering Myriad Genetics (NASDAQ:MYGN), 4 have Buy rating, 5 Sell and 11 Hold. Therefore 20% are positive. Myriad Genetics had 58 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Ladenburg Thalmann given on Wednesday, February 8. On Monday, August 14 the stock rating was maintained by Cowen & Co with “Hold”. On Wednesday, August 10 the stock rating was downgraded by PiperJaffray to “Neutral”. Goldman Sachs upgraded it to “Neutral” rating and $40 target in Tuesday, December 8 report. The rating was upgraded by Deutsche Bank on Friday, August 18 to “Hold”. UBS maintained it with “Sell” rating and $18 target in Wednesday, August 10 report. Morgan Stanley maintained the stock with “Underweight” rating in Friday, October 6 report. The stock has “Hold” rating by Jefferies on Wednesday, February 7. The rating was maintained by Morgan Stanley on Wednesday, November 8 with “Underweight”. As per Tuesday, August 25, the company rating was upgraded by Wells Fargo.

Among 24 analysts covering Proctor & Gamble (NYSE:PG), 12 have Buy rating, 0 Sell and 12 Hold. Therefore 50% are positive. Proctor & Gamble had 77 analyst reports since August 4, 2015 according to SRatingsIntel. As per Wednesday, October 12, the company rating was upgraded by Argus Research. UBS maintained the stock with “Neutral” rating in Wednesday, January 27 report. Goldman Sachs upgraded The Procter & Gamble Company (NYSE:PG) on Tuesday, January 16 to “Hold” rating. The stock of The Procter & Gamble Company (NYSE:PG) has “Buy” rating given on Monday, August 15 by B. Riley & Co. As per Thursday, July 27, the company rating was maintained by Stifel Nicolaus. The rating was initiated by Atlantic Securities with “Neutral” on Wednesday, January 6. The stock has “Sell” rating by Goldman Sachs on Monday, January 9. JP Morgan maintained the stock with “Neutral” rating in Wednesday, January 24 report. The company was downgraded on Wednesday, December 21 by Stifel Nicolaus. Suntrust Robinson upgraded the shares of PG in report on Tuesday, September 8 to “Buy” rating.

Investors sentiment decreased to 0.82 in 2017 Q3. Its down 0.12, from 0.94 in 2017Q2. It dropped, as 51 investors sold PG shares while 765 reduced holdings. 110 funds opened positions while 558 raised stakes. 1.50 billion shares or 1.10% more from 1.48 billion shares in 2017Q2 were reported. 439,206 are owned by Conning. Beck Mack Oliver Ltd Liability holds 0.32% of its portfolio in The Procter & Gamble Company (NYSE:PG) for 106,061 shares. Two Sigma Securities Ltd has invested 0.03% in The Procter & Gamble Company (NYSE:PG). Mitsubishi Ufj Secs Hldg Co Ltd holds 780 shares or 0.34% of its portfolio. Westchester Capital Mngmt Inc holds 3.37% or 86,508 shares in its portfolio. Fayez Sarofim Co accumulated 5.12M shares. Waldron LP invested 0.25% of its portfolio in The Procter & Gamble Company (NYSE:PG). Highland Cap Mngmt Limited Liability Com stated it has 1.24% of its portfolio in The Procter & Gamble Company (NYSE:PG). Invest Counsel Incorporated has invested 1.65% of its portfolio in The Procter & Gamble Company (NYSE:PG). Baillie Gifford And reported 0.04% of its portfolio in The Procter & Gamble Company (NYSE:PG). Gam Holdg Ag accumulated 31,657 shares or 0.12% of the stock. Barrett Asset Management Limited has 138,272 shares. Cadence Management Limited Liability Co holds 0.8% in The Procter & Gamble Company (NYSE:PG) or 141,459 shares. Grandfield And Dodd Ltd Liability Corp holds 1.57% or 153,475 shares in its portfolio. Arcadia Investment Mgmt Mi reported 0.3% stake.

Since August 15, 2017, it had 0 insider buys, and 3 selling transactions for $3.16 million activity. The insider Fish Kathleen B sold $144,688. Coombe Gary A sold $154,168 worth of stock. The insider Biegger Mark F sold $244,828. 20,175 shares were sold by Sheppard Valarie L, worth $1.87 million on Tuesday, August 22. Pritchard Marc S. also sold $4.17 million worth of The Procter & Gamble Company (NYSE:PG) shares. 3,490 shares were sold by FergusonMchugh MaryLynn, worth $321,221 on Tuesday, August 15.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>